Transdel Pharmaceuticals, Inc.
4225 Executive Square
Suite 485
La Jolla,
CA 92037
United States - Map
Phone: 858-457-5300
Fax: 858-457-5308
Web Site: http://www.transdelpharma.com
| Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company, develops non-invasive, topically-delivered medications in the United States. Its patented Transdel cream formulation technology is designed to facilitate the penetration of drugs through the skin barrier to reach the target underlying tissues. The company is developing its lead drug candidate, Ketotransdel, the Transdel cream that allows the active ingredient ketoprofen to reach the target soft tissue and exert its anti-inflammatory and analgesic effects. It is also investigating other drug candidates and treatments for transdermal delivery using its patented Transdel platform technology, for products in pain management and other therapeutic areas, and for cosmetic/cosmeceutical products. The companys co-development areas include hormone based products, and emetic and dermatological products. Transdel Pharmaceuticals, Inc. is headquartered in La Jolla, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Juliet Singh Ph.D., 50
Chairman, Chief Exec. Officer and Pres |
$
210.00K | N/A | Mr. John T. Lomoro , 40
Chief Financial Officer and Principal Accounting Officer |
$
160.00K | N/A | Dr. Joachim P. H. Schupp M.D., 56
Chief Medical Officer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
0.05 (4.35%) 
Profile
